Skip to main content

Richard Daly

CEO

Catalyst Pharmaceuticals, Inc.

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Richard Daly

Richard Daly is recorded as CEO at Catalyst Pharmaceuticals, Inc.. Richard Daly has spoken on 8 earnings calls across 1 company, most recently for Catalyst Pharmaceuticals, Inc. on September 30, 2025.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Catalyst Pharmaceuticals, Inc.

    CEO

    Proxy statement

    Current
  • Catalyst Pharmaceuticals, Inc.

    Board Member

    Proxy statement

    2024-01-01–2026-07-08

Company network

Recorded roles and call appearances connecting this person to public companies.

Catalyst Pharmaceuticals, Inc.

Current role

CEO

2024-01-01–present

8 appearances Latest appearance 2025-09-30

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

  • Earnings call

    Catalyst Pharmaceuticals, Inc. Q3 FY2025 Earnings Call

    Catalyst Pharmaceuticals, Inc.

  • Earnings call

    Catalyst Pharmaceuticals, Inc. Q2 FY2025 Earnings Call

    Catalyst Pharmaceuticals, Inc.

  • Earnings call

    Catalyst Pharmaceuticals, Inc. Q1 FY2025 Earnings Call

    Catalyst Pharmaceuticals, Inc.

  • Earnings call

    Catalyst Pharmaceuticals, Inc. Q4 FY2024 Earnings Call

    Catalyst Pharmaceuticals, Inc.

  • Earnings call

    Catalyst Pharmaceuticals, Inc. Q3 FY2024 Earnings Call

    Catalyst Pharmaceuticals, Inc.

  • Earnings call

    Catalyst Pharmaceuticals, Inc. Q2 FY2024 Earnings Call

    Catalyst Pharmaceuticals, Inc.

  • Earnings call

    Catalyst Pharmaceuticals, Inc. Q1 FY2024 Earnings Call

    Catalyst Pharmaceuticals, Inc.

  • Earnings call

    Catalyst Pharmaceuticals, Inc. Q4 FY2023 Earnings Call

    Catalyst Pharmaceuticals, Inc.